Chemical Structure : Tazemetostat
CAS No.: 1403254-99-8
Catalog No.: PC-21938Not For Human Use, Lab Use Only.
Tazemetostat (EPZ-6438) is a potent, selective, SMA-competitive and orally available EZH2 inhibitor with IC50 of 11 and 16 nM in peptide assay and nucleosome assay, respectively.
Packing | Price | Stock | Quantity |
---|---|---|---|
25 mg | $118 | In stock | |
50 mg | $168 | In stock | |
100 mg | $248 | In stock | |
200 mg | Get quote | ||
1 g | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Tazemetostat (EPZ-6438) is a potent, selective, SMA-competitive and orally available EZH2 inhibitor with IC50 of 11 and 16 nM in peptide assay and nucleosome assay, respectively.
Tazemetostat (EPZ-6438) inhibits the activity of human polycomb repressive complex 2 (PRC2)-containing wild-type EZH2 with Ki of 2.5 nM, inhibits rat EZH2 with IC50 of 4 nM.
Tazemetostat (EPZ-6438) selectively inhibits intracellular lysine 27 of histone H3 (H3K27) methylation in a concentration- and time-dependent manner in both EZH2 wild-type and mutant lymphoma cells.
Tazemetostat (EPZ-6438) treatment causes dose-dependent tumor growth inhibition in EZH2-mutant NHL xenograft-bearing mice.
M.Wt | 572.75 | |
Formula | C34H44N4O4 | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
N-((4,6-Dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-5-(ethyl(tetrahydro-2H-pyran-4-yl)amino)-4-methyl-4'-(morpholinomethyl)-[1,1'-biphenyl]-3-carboxamide |
1. Knutson SK, et al. Mol Cancer Ther. 2014 Apr;13(4):842-54.
2. Knutson SK, et al. PLoS One. 2014 Dec 10;9(12):e111840.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright